Increased liver stiffness denotes hepatic dysfunction and mortality risk in critically ill non-cirrhotic patients at a medical ICU
Authors:
Open Access
- 14 November 2011
- journal article
- research article
- Published by Springer Nature in Critical Care
- Vol. 15 (6) , R266
Abstract
Introduction: Hepatic dysfunction is a common finding in critically ill patients on the ICU and directly influences survival. Liver stiffness can be measured by the novel method of transient elastography (fibroscan) and is closely associated with hepatic fibrosis in patients with chronic liver disease, but also is increased in patients with acute hepatitis, acute liver failure and cholestasis. We investigated liver stiffness as a potentially useful tool for early detection of patients with hepatic deterioration and risk stratification with respect to short- and long-term mortality.Methods: We prospectively evaluated 108 consecutive critically ill patients at our medical intensive care unit (ICU) with subsequent longitudinal liver stiffness measurements (admission, Day 3, Day 7 and weekly thereafter) during the course of ICU treatment. Outcome was followed after discharge (median observation time 237 days).Results: Liver stiffness could be reliably measured in 71% of ICU patients at admission (65% at Day 3, 63% at Day 7). Critically ill patients (n= 108) had significantly increased liver stiffness compared to sex- and age-matched standard care patients (n= 25). ICU patients with decompensated cirrhosis showed highest liver stiffness, whereas other critical diseases (for example, sepsis) and comorbidities (for example, diabetes, obesity) did not impact stiffness values. At admission to the ICU, liver stiffness is closely related to hepatic damage (liver synthesis, cholestasis, fibrosis markers). During the course of ICU treatment, fluid overload (renal failure, volume therapy) and increased central venous pressure (mechanical ventilation, heart failure) were major factors determining liver stiffness. Liver stiffness values > 18 kilopascal (kPa) at ICU admission were associated with increased ICU and long-term mortality, even in non-cirrhotic patients.Conclusions: Considering that liver stiffness cannot be validly measured in about 30% of ICU patients, transient elastography performed at ICU admission might be a useful tool to early identify liver dysfunction and predict mortality in critically ill patients at a medical ICU.Keywords
This publication has 37 references indexed in Scilit:
- Comparison of Transient Elastography and Acoustic Radiation Force Impulse for Non-Invasive Staging of Liver Fibrosis in Patients With Chronic Hepatitis CAmerican Journal of Gastroenterology, 2011
- Liver stiffness accurately predicts portal hypertension related complications in patients with chronic liver disease: A prospective studyJournal of Hepatology, 2011
- Cross‐validation of MR elastography and ultrasound transient elastography in liver stiffness measurement: discrepancy in the results of cirrhotic liverJournal of Magnetic Resonance Imaging, 2011
- Risk Assessment of Esophageal Variceal Bleeding in B-Viral Liver Cirrhosis by a Liver Stiffness Measurement-Based ModelAmerican Journal of Gastroenterology, 2011
- Non-Invasive markers for hepatic fibrosisBMC Gastroenterology, 2011
- Hepatic stellate cells require a stiff environment for myofibroblastic differentiationAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2011
- Jaundice in critical illness: promoting factors of a concealed realityIntensive Care Medicine, 2006
- Elevation of Nε-(carboxymethyl)lysine-modified advanced glycation end products in chronic liver disease is an indicator of liver cirrhosisClinical Biochemistry, 2006
- Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis CGastroenterology, 2005
- Prognostic Value of the Indocyanine Green Plasma Disappearance Rate in Critically Ill PatientsChest, 2002